TSPO and brain disorder: This appears to be so, because in animal models, TSPO ligands, such as PK11195, Etifoxine, Emapunil, and 2-Cl-MGV-1, appear to be successful agents for treating brain disease and injury, in particular the neurodegenerative and neuroinflammatory components.